Michael H. Pillinger

Rheumatology

423 E 23rd St
New York, NY 10010

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 124 publications

Controversies in Urate-Lowering Therapy for Gout: A Comprehensive Review.

Controversies in Urate-Lowering Therapy for Gout: A Comprehensive Review.

Journal: Gout, urate, and crystal deposition disease

Published: August 18, 2026

Prevalence and Severity of Spinal Osteoarthritis in Gout Patients Versus Non-Gout Controls.

Prevalence and Severity of Spinal Osteoarthritis in Gout Patients Versus Non-Gout Controls.

Journal: Gout, urate, and crystal deposition disease

Published: August 18, 2026

CoLchicine for Treatment of OsteoArthritis of the Knee (CLOAK): Clinical and biochemical outcomes from a three-month double-blind, placebo-controlled study.

CoLchicine for Treatment of OsteoArthritis of the Knee (CLOAK): Clinical and biochemical outcomes from a three-month double-blind, placebo-controlled study.

Journal: Seminars in arthritis and rheumatism

Published: April 14, 2026

Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo-Controlled Phase 3 Trials.

Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo-Controlled Phase 3 Trials.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 24, 2025

Systemic inflammation in gout and the impact of treat-to-target urate-lowering therapy.

Systemic inflammation in gout and the impact of treat-to-target urate-lowering therapy.

Journal: Rheumatology (Oxford, England)

Published: September 04, 2025

Endothelial Cell and Neutrophil Activation in Untreated Intercritical Patients With Gout.

Endothelial Cell and Neutrophil Activation in Untreated Intercritical Patients With Gout.

Journal: The Journal of rheumatology

Published: July 01, 2025

Some More Equal Than Others: The Divergence of Cardiac Risk in the Use of Nonsteroidal Anti-Inflammatory Drugs Versus Colchicine for Treating and Preventing Gout.

Some More Equal Than Others: The Divergence of Cardiac Risk in the Use of Nonsteroidal Anti-Inflammatory Drugs Versus Colchicine for Treating and Preventing Gout.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 05, 2025

Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial.

Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial.

Journal: Seminars in arthritis and rheumatism

Published: May 05, 2025

Climate Change, Environmental Risk Factors, and Gout.

Climate Change, Environmental Risk Factors, and Gout.

Journal: Arthritis care & research

Published: May 02, 2025

Gout, Hyperuricemia, and the Intestinal Microbiome.

Gout, Hyperuricemia, and the Intestinal Microbiome.

Journal: Inflammation

Published: April 06, 2025

Prophylaxis of Gout Flares in Patients with Renal Impairment: Dosing Adjustments with Colchicine Oral Solution Informed by a Pharmacokinetic Model.

Prophylaxis of Gout Flares in Patients with Renal Impairment: Dosing Adjustments with Colchicine Oral Solution Informed by a Pharmacokinetic Model.

Journal: Rheumatology and therapy

Published: February 14, 2025

Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial.

Improvements in Health-Related Quality of Life With Treat-to-Target Urate-Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial.

Journal: Arthritis care & research

Published: February 06, 2025

Showing 1-12 of 124

Last Updated: 09/26/2026